In this video - recorded on Dec 29, 2024 - MDB Capital Group’s Lou Basenese interviews Invizyne Technologies’ CEO Michael Heltzen about the core technology behind Invizyne's platform and how it's based on no less than four current Nobel Prizes in chemistry.  

What’s more, while everyone is preoccupied with talking about AI in terms of Nvidia Corp.’s (#NVDA) impressive growth, the two discuss how AI is also dramatically impacting and accelerating Invizyne’s enzyme engineering capabilities.

“Why does this matter? It's a new generation of access to chemicals. A new way where we don't use oil as a starting point. What is chemistry? It's your good life. It's what you're wearing right now. It is the sofa behind you. It is the paint on your walls. It is the colors you see in all materials. It is also in your food and in your medicine, in the fragrance and the flavors that makes the good life,” said Heltzen.

Stay tuned for Part 3 about Invizyne’s Go-To-Market strategy. And please remember to follow Michael Heltzen and Invizyne to be sure to get all future updates as well!